A Bioengineered Model of Tumor Vessel Interactions in Pancreatic Cancer

胰腺癌肿瘤血管相互作用的生物工程模型

基本信息

  • 批准号:
    10373531
  • 负责人:
  • 金额:
    $ 18.32万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-02-01 至 2024-01-31
  • 项目状态:
    已结题

项目摘要

Pancreatic ductal adenocarcinoma (PDAC) is a leading cause of cancer deaths among malignancies. PDAC is highly invasive and forms metastases in distant organs at the very early stage of tumor progression. To better understand PDAC metastasis, tumor-blood vessel interactions need to be evaluated further, as tumor cells spread primarily through the blood circulation. However, how PDAC interacts with blood vessels and establishes distant metastases are poorly understood. Recently, our study using both three-dimensional (3D) biomimetic PDAC-on-chip and multiple in vivo mouse models showed that PDAC cells invaded blood vasculatures and actively replaced endothelial cells via ALK7 signaling, leading to a formation of tumor-vessel hybrid structure in PDAC tumors. We refer to this phenomenon as tumor vessel replacement. Despite the novelty of the finding, it is unknown what the biological consequences of the tumor vessel replacement in PDAC are. Understanding the phenotypic consequences of the tumor vessel replacement is critical to determine the clinical relevance and significance of blocking ALK7 in PDAC. We hypothesize that PDAC tumor vessel replacement increases tumor vessel permeability; then promotes tumor intravasation and metastasis by facilitating tumor cells’ entering the blood circulation through the leakier vessels. In order to test these hypotheses, we aim to determine—in both in vitro and in vivo—(i) if tumor vessel replacement induces tumor vessel leakiness and promotes metastatic dissemination and (ii) if ALK7 inhibition or ALK7 knock out (KO) ameliorates or reverses tumor vessel leakiness and metastasis. In Aim 1, we will assess the role of ALK7 in PDAC vessel permeability in pericyte-covered blood vessel on-chip by co-culturing microvascular endothelial cells and pericytes to mimic physiological blood vessels surrounded by pericytes (Aim 1.1). Next, we will evaluate the role of ALK7 in PDAC vessel dysfunction in vivo. We will generate an orthotopic PDAC model using wild-type or ALK7-KO PDAC cells, and examine PDAC tumor vessel permeability by intravenously injecting dextran molecules (Aim 1.2). In Aim 2, we will examine ALK7 in PDAC metastasis in vitro by establishing pre-metastatic liver microenvironment in the reservoirs that are connected to the engineered blood vessel. Multiple PDAC lines will be assessed to test whether ALK7-mediated tumor vessel replacement affects metastatic spreading (Aim 2.1). We will then evaluate the role of ALK7 in PDAC metastasis in vivo using human patient-derived xenograft (PDX) models in collaboration with Dr. Manuel Hidalgo. Metastatic tumor burdens in control vs. ALK7 KO groups will be assessed, and the number of circulating tumor cells and overall survival rate will be determined (Aim 2.2). In summary, our 3D PDAC-on-chip system will provide a unique platform to better investigate PDAC interactions with blood vessels and metastatic progression. We will decipher the roles of ALK7 signaling in mediating tumor vessel dysregulation and metastasis; and assess whether we will be able to reduce PDAC progression and metastasis by targeting ALK7.
胰腺导管腺癌(PDAC)是恶性肿瘤中癌症死亡的主要原因。 PDAC 是 具有高度侵袭性,并在肿瘤进展的早期阶段在远处器官中形成转移。为了更好 为了了解 PDAC 转移,需要进一步评估肿瘤与血管的相互作用,因为肿瘤细胞 主要通过血液循环传播。然而,PDAC 如何与血管相互作用并建立 对远处转移知之甚少。最近,我们的研究使用三维(3D)仿生技术 PDAC 芯片和多个体内小鼠模型表明 PDAC 细胞侵入血管并 通过 ALK7 信号传导主动替换内皮细胞,导致肿瘤-血管混合结构的形成 PDAC 肿瘤。我们将这种现象称为肿瘤血管替代。尽管这一发现很新颖, PDAC 中肿瘤血管置换的生物学后果尚不清楚。了解 肿瘤血管置换的表型后果对于确定临床相关性和 阻断 PDAC 中 ALK7 的意义。我们假设 PDAC 肿瘤血管置换会增加肿瘤 血管渗透性;然后通过促进肿瘤细胞进入肿瘤细胞来促进肿瘤的浸润和转移。 血液循环通过渗漏的血管。为了检验这些假设,我们的目标是确定——在 体外和体内——(i) 如果肿瘤血管置换引起肿瘤血管渗漏并促进转移 (ii) ALK7 抑制或 ALK7 敲除 (KO) 是否改善或逆转肿瘤血管渗漏 和转移。在目标 1 中,我们将评估 ALK7 在周细胞覆盖的血液中 PDAC 血管通透性中的作用 通过共培养微血管内皮细胞和周细胞来模拟生理血管,从而实现芯片上血管 被周细胞包围(目标 1.1)。接下来,我们将评估 ALK7 在体内 PDAC 血管功能障碍中的作用。 我们将使用野生型或 ALK7-KO PDAC 细胞生成原位 PDAC 模型,并检查 PDAC 肿瘤 通过静脉注射葡聚糖分子来测量血管通透性(目标 1.2)。在目标 2 中,我们将检查 ALK7 通过在储库中建立转移前肝脏微环境来进行体外 PDAC 转移 连接到工程血管。将评估多个 PDAC 系以测试 ALK7 是否介导 肿瘤血管置换影响转移扩散(目标 2.1)。然后我们将评估 ALK7 在 PDAC 中的作用 与 Manuel Hidalgo 博士合作,使用人类患者来源的异种移植 (PDX) 模型进行体内转移。 将评估对照组与 ALK7 KO 组的转移性肿瘤负荷,以及循环肿瘤的数量 将确定细胞和总体存活率(目标 2.2)。总之,我们的 3D PDAC 片上系统将提供 一个独特的平台,可以更好地研究 PDAC 与血管和转移进展的相互作用。我们将 破译 ALK7 信号传导在介导肿瘤血管失调和转移中的作用;并评估 我们是否能够通过靶向 ALK7 来减少 PDAC 进展和转移。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Esak Lee其他文献

Esak Lee的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Esak Lee', 18)}}的其他基金

Tissue-Engineered Models of Lymphatic Drainage in Breast Cancer
乳腺癌淋巴引流的组织工程模型
  • 批准号:
    10637169
  • 财政年份:
    2023
  • 资助金额:
    $ 18.32万
  • 项目类别:
Regulation of Lymphatic Endothelial Cell Junction and Drainage
淋巴内皮细胞连接和引流的调节
  • 批准号:
    10502991
  • 财政年份:
    2022
  • 资助金额:
    $ 18.32万
  • 项目类别:
A Bioengineered Model of Tumor Vessel Interactions in Pancreatic Cancer
胰腺癌肿瘤血管相互作用的生物工程模型
  • 批准号:
    10557226
  • 财政年份:
    2022
  • 资助金额:
    $ 18.32万
  • 项目类别:
Regulation of Lymphatic Endothelial Cell Junction and Drainage
淋巴内皮细胞连接和引流的调节
  • 批准号:
    10642883
  • 财政年份:
    2022
  • 资助金额:
    $ 18.32万
  • 项目类别:
A Bioengineered Model for Deciphering Lymphatic Dysfunction in Inflammation
破译炎症中淋巴功能障碍的生物工程模型
  • 批准号:
    10493273
  • 财政年份:
    2021
  • 资助金额:
    $ 18.32万
  • 项目类别:
A Bioengineered Model for Deciphering Lymphatic Dysfunction in Inflammation
破译炎症中淋巴功能障碍的生物工程模型
  • 批准号:
    10354568
  • 财政年份:
    2021
  • 资助金额:
    $ 18.32万
  • 项目类别:

相似海外基金

How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
  • 批准号:
    BB/Z514391/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.32万
  • 项目类别:
    Training Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
  • 批准号:
    2312555
  • 财政年份:
    2024
  • 资助金额:
    $ 18.32万
  • 项目类别:
    Standard Grant
RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
  • 批准号:
    2327346
  • 财政年份:
    2024
  • 资助金额:
    $ 18.32万
  • 项目类别:
    Standard Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
  • 批准号:
    ES/Z502595/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.32万
  • 项目类别:
    Fellowship
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
  • 批准号:
    23K24936
  • 财政年份:
    2024
  • 资助金额:
    $ 18.32万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
  • 批准号:
    ES/Z000149/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.32万
  • 项目类别:
    Research Grant
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
  • 批准号:
    2901648
  • 财政年份:
    2024
  • 资助金额:
    $ 18.32万
  • 项目类别:
    Studentship
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
  • 批准号:
    488039
  • 财政年份:
    2023
  • 资助金额:
    $ 18.32万
  • 项目类别:
    Operating Grants
New Tendencies of French Film Theory: Representation, Body, Affect
法国电影理论新动向:再现、身体、情感
  • 批准号:
    23K00129
  • 财政年份:
    2023
  • 资助金额:
    $ 18.32万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The Protruding Void: Mystical Affect in Samuel Beckett's Prose
突出的虚空:塞缪尔·贝克特散文中的神秘影响
  • 批准号:
    2883985
  • 财政年份:
    2023
  • 资助金额:
    $ 18.32万
  • 项目类别:
    Studentship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了